CLINICAL_TRIALS
trial_result
· 2025-04-04
Clinical Trial Update: A Study of DS-7011a in Patients With Systemic Lupus Erythematosus [Phase 1, Phase 2]
Summary
A completed Phase 1/2 clinical trial evaluating DS-7011a in patients with systemic lupus erythematosus.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Daiichi Sankyo | Conditions: Systemic Lupus Erythematosus | Phase 1, Phase 2 | Status: COMPLETED